Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2-Reference-Cited by-同舟云学术

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2

Published:2020-10-25 Issue:12 Volume:11 Page:2526-2533
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Ghahremanpour Mohammad M.¹^ORCID,Tirado-Rives Julian¹^ORCID,Deshmukh Maya²,Ippolito Joseph A.¹²,Zhang Chun-Hui¹,Cabeza de Vaca Israel¹,Liosi Maria-Elena¹,Anderson Karen S.²³^ORCID,Jorgensen William L.¹^ORCID

Affiliation:

1. Department of Chemistry, Yale University, New Haven, Connecticut 06520-8107, United States,

2. Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520-8066, United States and

3. Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06520-8066, United States

Funder

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00521

Reference34 articles.

1. A new coronavirus associated with human respiratory disease in China

2. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

3. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

4. Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur

5. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are protein–ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?;Drug Discovery Today;2024-10

2. Identifying Artifacts from Large Library Docking;Journal of Medicinal Chemistry;2024-09-10

3. Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective;Gene;2024-09

4. An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease;Microbiology Spectrum;2024-08-20

5. Organometallic–Erlotinib Conjugates Active against Lung Cancer Cells and as Emerging Virus Entry Inhibitors;Organometallics;2024-07-22